Jan Skvarka - 09 Sep 2022 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
Issuer symbol
ZNTL
Transactions as of
09 Sep 2022
Net transactions value
$0
Form type
3
Filing time
12 Sep 2022, 07:06:17 UTC
Previous filing
19 Nov 2021
Next filing
24 Mar 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney